LB Pharmaceuticals Inc (LBRX)

NASDAQ: LBRX · Real-Time Price · USD

24.34

-1.95 (-7.42%)

At close: Apr 10, 2026, 4:00 PM EDT

24.71

+0.37 (1.52%)

After-hours: Apr 10, 2026, 6:31 PM EDT

LB Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	616	563	-	-	-
Enterprise Value	324	252	-	-	-
Last Close Price	24.34	22.26	-	-	-
PB Ratio	2.04	1.87	-	-	-
P/TBV Ratio	2.04	1.87	-	-	-
Debt / Equity Ratio	0.01	0.01	0.19	-	-1.12
Net Debt / Equity Ratio	-0.97	-0.97	-1.23	-1.04	-0.13
Net Debt / EBITDA Ratio	9.99	9.99	0.38	3.81	-0.98
Net Debt / FCF Ratio	8.27	8.27	0.45	3.57	-1.01
Quick Ratio	39.67	39.67	3.45	16.61	45.64
Current Ratio	41.45	41.45	3.56	17.51	45.82
Return on Equity (ROE)	-15.70%	-15.70%	-206.22%	-63.14%	-
Return on Assets (ROA)	-10.64%	-10.64%	-102.33%	-21.18%	-
Return on Capital Employed (ROCE)	-9.70%	-9.70%	-255.00%	-26.40%	-13.40%
Earnings Yield	-4.09%	-4.48%	-	-	-
FCF Yield	-5.73%	-6.26%	-	-	-
Buyback Yield / Dilution	-2145.81%	-2145.81%	-43.52%	-8.02%	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q